Actualités

One crucial launch milestone could determine whether the bet pays

Rocket Lab (RKLB) delivered the type of quarter that should have put investors at ease. Revenue jumped62% year over year to a record $234 million, beating Wall Street expectations, while its space-systems business accounted for 81% of total sales. Instead, shares fell roughly 7% in extended ...

Futures for the Dow Jones Industrial Average and the other major stock indexes traded higher Tuesday, after it was reported the U.S. and Iran had reached "some sort of an arrangement" for a peace deal.

Shares of Rocket Lab traded down more than 4% premarket after the company indicated its forthcoming Neutron vehicle may not be ready to launch this year. The company said Monday it is planning to deliver the first Neutron rocket to a launch pad in the last quarter of 2026. In May, Rocket Lab said it was in position to debut the rocket this year.

Aerospace and defense company Rocket Lab (NASDAQ:RKLB) will be reporting results this Monday after the bell. Here’s what you need to know.

The space company posted $234 million in second-quarter revenue, up 62% year over year, but a per-share loss that missed analyst estimates

Rocket Lab Corp (RKLB) posts 62% revenue growth to $234 million, secures over $1 billion in new contracts, and advances Neutron development toward a Q4 2026 pad delivery.

Rocket Lab (NASDAQ:RKLB) reported record second-quarter 2026 revenue of $234 million, up 62% from a year earlier and 16.8% sequentially, as the company expanded its Space Systems business, added major government contracts and continued development of its Neutron medium-lift rocket. Founder and Chie

Dow Jones Futures: Surging oil prices sparked stock market losses Monday. SpaceX rival Rocket Lab tumbled on earnings late.

Rocket Lab Corp. (NASDAQ:RKLB) reports second-quarter earnings Monday after the close, with investors listening for an update on Neutron. Prediction market traders are overwhelmingly skeptical the company’s next-generation rocket flies this year. Traders on Kalshi assign just a 14% probability...

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from SpaceX last week. - Moderna (MRNA) shares are moving after last week's news that its mRNA flu shot won US approval in an FDA turnaround. - Intel (INTC) shares are moving after the company said it will be offering $15 billion in common stock, taking advantage of renewed interest in its business prospects during the artificial intelligence data center boom.

Rocket Lab stock rose slightly ahead of its earnings report on Monday. Shares rallied 27% last week.

Rocket Lab heads into today's Q2 earnings with four tailwinds—an impressive launch track record, new Space Force contracts, an $8 billion acquisition, and strong sector-wide demand signals from SpaceX's debut report.

The benchmark US stock measures were mostly pointing higher before the opening bell Monday as trader

This week is much more sedate on the earnings front after a busy few weeks, which could be a good or a bad thing depending on your approach. This week we have Cisco Systems, RocketLab, CoreWeave and Applied Materials as the main companies reporting.

US equity investors are expected to focus on inflation and Fed speak this week while keeping a close

Retail traders appear to be more interested in RKLB. RKLB’s watcher count increased 16% over three months and 56% over a year, versus 12% and 47% for ASTS.

Monday Earnings (a.m): Barrick Mining Earnings (p.m.): Simon Property, Rocket Lab, JBS, Hims & Hers Health, Trump Media Tuesday Economic data: NFIB small-business index for July, existing home sales Earnings: Cardinal Health, Lumentum, CoreWeave, Super Micro, On Holding, Smithfield Foods Wednesday Inflation data: Consumer price index for July, 8:30 a.

Economic news this week will include data on consumer and producer prices, existing-home sales, and small-business optimism. As earnings season winds down, we’ll see results from Simon Property, Applied Materials, Cava, and more.

TransDigm Group (NYSE:TDG) raised its fiscal 2026 sales, EBITDA and commercial aftermarket outlook after reporting third-quarter results that management said exceeded expectations, supported by growth across commercial OEM, commercial aftermarket and defense markets. President and Chief Executive O

Retail sentiment toward both stocks improved to ‘bullish,’ but RKLB leads in watcher growth and share-price performance.

SpaceX revenue growth is seen ramping up, but capex too. Elon Musk may detail Falcon 9, Starship and Tesla plans.

Rocket Lab is rapidly transforming from a launch company into a diversified space business, positioning it for profits and strong free cash flow as early as next year.

The sky may not be the limit for the company, which provides satellite launch services.

IPO Edge hosted a fireside chat on July 28 from the floor of the New York Stock Exchange with Don Duffy, President and Chairman of the Board of ICR […]

The U.S. Transportation Department and the Federal Aviation Administration (FAA) have proposed sweeping rules to grant environmental review waivers for commercial rocket launches and spaceport operations, bypassing long-standing regulatory hurdles.

SpaceX's post-IPO collapse left nearly every early buyer underwater, yet one Wall Street firm just slapped an $800 price target on a stock trading near $113. Here is what the bulls see that the market is choosing to ignore.

Rocket Lab’s share price pops as management announces a landmark contract with the USSF. Here’s what the federal agreement really means for RKLB stock.

The U.S. Department of Defense has entered an aggressive new era of spending this year. Before launching into its massive new tech overhauls, it kicked off the momentum with a $266 million firm-fixed-price contract awarded to Rocket Lab for 12 suborbital launches. But aerospace isn't the only ...

IRDM's revenue beat estimates as new satellite products, Aireon and Rocket Lab deals reshape its growth strategy despite an EPS miss.